Eukles Asset Management’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $750K | Sell |
15,730
-489
| -3% | -$22.7K | 0.31% | 60 |
|
|
2026
Q1 | $711K | Sell |
16,219
-6,318
| -28% | -$288K | 0.32% | 63 |
|
|
2025
Q4 | $999K | Sell |
22,537
-115
| -0.5% | -$4.95K | 0.39% | 62 |
|
|
2025
Q3 | $956K | Sell |
22,652
-50
| -0.2% | -$2.02K | 0.37% | 65 |
|
|
2025
Q2 | $832K | Sell |
22,702
-50
| -0.2% | -$1.86K | 0.34% | 66 |
|
|
2025
Q1 | $866K | Buy |
22,752
+1,826
| +9% | +$67.9K | 0.38% | 66 |
|
|
2024
Q4 | $792K | Buy |
20,926
+43
| +0.2% | +$1.72K | 0.34% | 66 |
|
|
2024
Q3 | $850K | Buy |
20,883
+93
| +0.4% | +$3.52K | 0.34% | 66 |
|
|
2024
Q2 | $712K | Buy |
20,790
+269
| +1% | +$8.47K | 0.31% | 68 |
|
|
2024
Q1 | $650K | Buy |
20,521
+1,065
| +5% | +$32.4K | 0.28% | 70 |
|
|
2023
Q4 | $597K | Sell |
19,456
-35
| -0.2% | -$1.12K | 0.28% | 69 |
|
|
2023
Q3 | $646K | Buy |
19,491
+267
| +1% | +$8.53K | 0.34% | 67 |
|
|
2023
Q2 | $590K | Buy |
19,224
+708
| +4% | +$20.5K | 0.3% | 67 |
|
|
2023
Q1 | $508K | Buy |
18,516
+477
| +3% | +$13.3K | 0.28% | 68 |
|
|
2022
Q4 | $504K | Buy |
18,039
+2,997
| +20% | +$90.4K | 0.29% | 69 |
|
|
2022
Q3 | $444K | Buy |
15,042
+452
| +3% | +$14.2K | 0.29% | 72 |
|
|
2022
Q2 | $411K | Buy |
14,590
+446
| +3% | +$12.7K | 0.26% | 75 |
|
|
2022
Q1 | $441K | Buy |
14,144
+103
| +0.7% | +$3.04K | 0.24% | 79 |
|
|
2021
Q4 | $415K | Buy |
14,041
+801
| +6% | +$23.4K | 0.2% | 82 |
|
|
2021
Q3 | $397K | Buy |
13,240
+2,704
| +26% | +$93K | 0.22% | 79 |
|
|
2021
Q2 | $382K | Buy |
10,536
+2,199
| +26% | +$81.6K | 0.21% | 77 |
|
|
2021
Q1 | $305K | Buy |
8,337
+1,125
| +16% | +$41.4K | 0.2% | 79 |
|
|
2020
Q4 | $262K | Sell |
7,212
-46
| -0.6% | -$1.56K | 0.18% | 80 |
|
|
2020
Q3 | $217K | Sell |
7,258
-60
| -0.8% | -$1.87K | 0.17% | 83 |
|
|
2020
Q2 | $217K | Sell |
7,318
-387
| -5% | -$11.5K | 0.18% | 83 |
|
|
2020
Q1 | $205K | Buy |
7,705
+320
| +4% | +$12.1K | 0.21% | 77 |
|
|
2019
Q4 | $313K | Buy |
7,385
+54
| +0.7% | +$2.29K | 0.26% | 74 |
|
|
2019
Q3 | $306K | Buy |
7,331
+128
| +2% | +$4.99K | 0.27% | 75 |
|
|
2019
Q2 | $265K | Sell |
7,203
-43
| -0.6% | -$1.57K | 0.23% | 78 |
|
|
2019
Q1 | $276K | Buy |
7,246
+390
| +6% | +$14.5K | 0.25% | 75 |
|
|
2018
Q4 | $241K | Buy |
+6,856
| New | +$238K | 0.25% | 75 |
|
Other funds holding OHI
Eukles Asset Management's OHI Position: Q2 2026 in Review
Eukles Asset Management reduced its Omega Healthcare (OHI) stake by 3% in Q2 2026, selling an estimated $22.7K and leaving 15,730 shares worth $750K. The position accounts for 0.31% of the portfolio, ranked #60.
Eukles Asset Management first reported a position in OHI in Q4 2018 and has held it in 31 quarters since. The position peaked at $999K in Q4 2025. 762 funds tracked by Wall St. Rank hold OHI as of Q2 2026.
- Eukles Asset Management held 15,730 shares of Omega Healthcare worth $750K as of Q2 2026.
- Eukles Asset Management sold 489 Omega Healthcare shares in Q2 2026, an estimated $22.7K.
- Omega Healthcare made up 0.31% of Eukles Asset Management's portfolio in Q2 2026, its #60 holding.
- Eukles Asset Management first reported a position in Omega Healthcare in Q4 2018 and has held it in 31 quarters since.
- Eukles Asset Management's Omega Healthcare position peaked at $999K in Q4 2025.
- 762 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.
Based on Eukles Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.